A real-world pharmacovigilance study of lorazepam based on the FDA adverse event reporting system database

Abstract Lorazepam is extensively used to treat anxiety disorders and anxiety associated with depression. This study evaluates the safety of lorazepam based on real-world data from the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS). Data were collected from January 2004 to...

Descripción completa

Detalles Bibliográficos

Autores principales:	Chunyue Fang, Xiaoyan Xu, Jianyi Li, Yuanyuan Zhong, Wei Dai, Jin Wen, Qionghui Yang, Ruixiang Chen
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	Nature Portfolio 2025-06-01
Colección:	Scientific Reports
Materias:	Anxiety Lorazepam Pharmacovigilance FAERS Adverse events
Acceso en línea:	https://doi.org/10.1038/s41598-025-05680-z
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!